XML 28 R19.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Segment Information | 9 Months Ended
--- | ---
Sep. 30, 2022
Segment Reporting [Abstract] |
Segment Information | Segment Information The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments. Net sales by segment were as follows:
| Three Months Ended |  | Nine Months Ended |  |
| September 30, |  | September 30, |  |
| 2022 |  | 2021 |  | 2022 |  | 2021 |  |  |  |
Net sales |  |  |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |  |  |
North America | $ | 958 |  |  | $ | 931 |  |  | $ | 2,850 |  |  | $ | 2,765 |  |  |  |  |
Latin America | 997 |  |  | 931 |  |  | 2,970 |  |  | 2,745 |  |  |  |  |
Europe | 632 |  |  | 718 |  |  | 1,925 |  |  | 2,144 |  |  |  |  |
Asia Pacific | 709 |  |  | 731 |  |  | 2,131 |  |  | 2,142 |  |  |  |  |
Africa/Eurasia | 287 |  |  | 258 |  |  | 809 |  |  | 796 |  |  |  |  |
Total Oral, Personal and Home Care | 3,583 |  |  | 3,569 |  |  | 10,685 |  |  | 10,592 |  |  |  |  |
Pet Nutrition | 872 |  |  | 845 |  |  | 2,653 |  |  | 2,426 |  |  |  |  |
Total Net sales | $ | 4,455 |  |  | $ | 4,414 |  |  | $ | 13,338 |  |  | $ | 13,018 |  |  |  |  |
Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
| Three Months Ended |  | Nine Months Ended |  |
| September 30, |  | September 30, |  |
| 2022 |  | 2021 |  | 2022 |  | 2021 |  |  |  |
Net sales |  |  |  |  |  |  |  |  |  |  |
Oral Care | 44 | % |  | 44 | % |  | 44 | % |  | 44 | % |  |  |  |
Personal Care | 19 | % |  | 20 | % |  | 19 | % |  | 20 | % |  |  |  |
Home Care | 17 | % |  | 18 | % |  | 17 | % |  | 17 | % |  |  |  |
Pet Nutrition | 20 | % |  | 18 | % |  | 20 | % |  | 19 | % |  |  |  |
Total Net sales | 100 | % |  | 100 | % |  | 100 | % |  | 100 | % |  |  |  |
Operating profit by segment was as follows:
| Three Months Ended |  | Nine Months Ended |  |
| September 30, |  | September 30, |  |
| 2022 |  | 2021 |  | 2022 |  | 2021 |  |  |  |
Operating profit |  |  |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |  |  |
North America | $ | 198 |  |  | $ | 183 |  |  | $ | 557 |  |  | $ | 585 |  |  |  |  |
Latin America | 289 |  |  | 248 |  |  | 818 |  |  | 774 |  |  |  |  |
Europe | 127 |  |  | 178 |  |  | 410 |  |  | 524 |  |  |  |  |
Asia Pacific | 185 |  |  | 215 |  |  | 556 |  |  | 639 |  |  |  |  |
Africa/Eurasia | 66 |  |  | 44 |  |  | 160 |  |  | 153 |  |  |  |  |
Total Oral, Personal and Home Care | 865 |  |  | 868 |  |  | 2,501 |  |  | 2,675 |  |  |  |  |
Pet Nutrition | 201 |  |  | 233 |  |  | 617 |  |  | 661 |  |  |  |  |
Corporate | (119) |  |  | (134) |  |  | (427) |  |  | (369) |  |  |  |  |
Total Operating profit | $ | 947 |  |  | $ | 967 |  |  | $ | 2,691 |  |  | $ | 2,967 |  |  |  |  |
Corporate Operating profit (loss) for the three and nine months ended September 30, 2022 included charges resulting from the 2022 Global Productivity Initiative of $3 and $79, respectively, a gain on the sale of land in Asia Pacific of $47 in both periods and acquisition-related costs of $17 in both periods. Corporate Operating profit (loss) for the nine months ended September 30, 2021 included a benefit related to a value-added tax matter in Brazil of $26.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI https://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration